Scholarlink

Purpose <p>Migraine and insomnia frequently co-occur, sharing neural pathways and neurotransmitters, complicating treatment. Cognitive behavioural therapy (CBT) is an established intervention for insomnia and chronic pain, but its role in migraine with comorbid insomnia remains unclear.</p> Methods <p>Following PRISMA guidelines, a systematic review and meta-analysis of PubMed, Cochrane, and Google Scholar databases (inception–12 August 2024) identified studies assessing CBT in patients with migraine and insomnia. Outcomes included treatment engagement, sleep parameters, and headache characteristics.</p> Results <p>Four studies (137 participants, mean age 30 years) met the inclusion criteria. Treatment feasibility ranged from 80 to 90% and acceptability exceeded 80%. Pooled analysis revealed a significant reduction in migraine severity (MD = − 0.55, 95% CI: − 0.97 to − 0.12) but no significant change in migraine disability (MIDAS), sleep efficiency, or total sleep hours. Qualitative synthesis suggested improvements in sleep quality and headache frequency. Findings indicated variability by age group, intervention format, and assessment methods.</p> Conclusion <p>Preliminary evidence suggest that CBT may be beneficial in reducing migraine severity and frequency in patients with comorbid insomnia, though effects on disability and objective sleep metrics are inconsistent. Heterogeneity in study designs and small sample sizes limits generalisability. Larger, standardised trials are warranted to optimise CBT protocols and explore integration with pharmacological therapies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The role of cognitive behavioural therapy in migraine with co-existing insomnia: systematic review and meta-analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月19日

查看全文
  • Leladher Maheshwari,
  • Shayan Ali Irfan,
  • Amina Hassan,
  • Ali Ahmed,
  • Inshaal Jaffery,
  • Fiza Kazmi,
  • Phanish Ravi,
  • Javed Iqbal

摘要

Purpose

Migraine and insomnia frequently co-occur, sharing neural pathways and neurotransmitters, complicating treatment. Cognitive behavioural therapy (CBT) is an established intervention for insomnia and chronic pain, but its role in migraine with comorbid insomnia remains unclear.

Methods

Following PRISMA guidelines, a systematic review and meta-analysis of PubMed, Cochrane, and Google Scholar databases (inception–12 August 2024) identified studies assessing CBT in patients with migraine and insomnia. Outcomes included treatment engagement, sleep parameters, and headache characteristics.

Results

Four studies (137 participants, mean age 30 years) met the inclusion criteria. Treatment feasibility ranged from 80 to 90% and acceptability exceeded 80%. Pooled analysis revealed a significant reduction in migraine severity (MD = − 0.55, 95% CI: − 0.97 to − 0.12) but no significant change in migraine disability (MIDAS), sleep efficiency, or total sleep hours. Qualitative synthesis suggested improvements in sleep quality and headache frequency. Findings indicated variability by age group, intervention format, and assessment methods.

Conclusion

Preliminary evidence suggest that CBT may be beneficial in reducing migraine severity and frequency in patients with comorbid insomnia, though effects on disability and objective sleep metrics are inconsistent. Heterogeneity in study designs and small sample sizes limits generalisability. Larger, standardised trials are warranted to optimise CBT protocols and explore integration with pharmacological therapies.